When Congress resumes next month, the BioSecure Act will be one of its top priorities. The bill, which could dramatically reorder the global pharmaceutical supply...
In recent years, several large Chinese companies have filed defamation suits against small organizations or individual researchers, leading to a strange reality: Even as the...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy